Table 3

Andersen-Gill model for the end point RFS

RFS
Prognostic markersHR95% CIP
Allogeneic HSCT 0.23 0.11-0.51 <.001 
Autologous HSCT 0.37 0.17-0.80 .012 
Log10(WBC) 1.40 0.77-2.56 .27 
Log10(platelets) 0.81 0.40-1.66 .57 
% BM blasts (difference 10%) 0.94 0.82-1.08 .40 
Age (difference of 10 y) 0.86 0.68-1.08 .20 
Abnormal karyotype 0.73 0.38-1.40 .35 
RFS
Prognostic markersHR95% CIP
Allogeneic HSCT 0.23 0.11-0.51 <.001 
Autologous HSCT 0.37 0.17-0.80 .012 
Log10(WBC) 1.40 0.77-2.56 .27 
Log10(platelets) 0.81 0.40-1.66 .57 
% BM blasts (difference 10%) 0.94 0.82-1.08 .40 
Age (difference of 10 y) 0.86 0.68-1.08 .20 
Abnormal karyotype 0.73 0.38-1.40 .35 

WBC, white blood cell count.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal